BenzingaApr 14, 5:12 AM ET▲ Positive
Stock surged 20.25% in premarket following announcement of strategic collaboration with Mayo Clinic for SC451 development and $25 million investment from Mayo Clinic at $3.33 per share.
Sana Biotechnology news
$2.91−0.68%
Close Sep 29, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About Sana Biotechnology
Also mentions SANA
Articles that tag SANA but are mainly about other companies.
BenzingaApr 17, 1:23 PM ETNeutral
Referenced as previous largest biotech IPO (2021) at $676 million; no direct involvement in obesity drug race; mentioned only for historical IPO comparison
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology